Horan Securities, Inc. Amgen Inc Transaction History

Horan Securities, Inc.

$257 Million
Q3 2024

A detailed history of Horan Securities, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Horan Securities, Inc. holds 1,457 shares of AMGN stock, worth $422,384. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,457

Previous 1,452 0.34%

Holding current value

$422,384

Previous $453,000 3.53%

% of portfolio

0.18%

Previous 0.2%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $1,546 - $1,686	5 Added 0.34%	1,457 $469,000
Q1 2024 May 02, 2024	SELL	$268.87 - $324.56 $537 - $649	-2 Reduced 0.14%	1,452 $412,000
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $32,729 - $36,922	128 Added 9.65%	1,454 $418,000
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $437 - $542	2 Added 0.15%	1,326 $356,000
Q2 2023 Jul 27, 2023	BUY	$214.27 - $253.37 $15,213 - $17,989	71 Added 5.67%	1,324 $293,000
Q1 2023 Apr 18, 2023	BUY	$225.79 - $275.2 $270,948 - $330,240	1,200 Added 2264.15%	1,253 $302,000
Q4 2022 Jan 17, 2023	BUY	$229.03 - $291.01 $5,496 - $6,984	24 Added 82.76%	53 $0
Q3 2022 Oct 12, 2022	SELL	$224.46 - $253.15 $224 - $253	-1 Reduced 3.33%	29 $7,000
Q2 2022 Jul 19, 2022	BUY	$230.71 - $256.74 $5,075 - $5,648	22 Added 275.0%	30 $7,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $7,544 - $8,792	-34 Reduced 80.95%	8 $2,000
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $4,976 - $5,926	23 Added 121.05%	42 $10,000
Q3 2020 Nov 04, 2020	SELL	$234.65 - $260.95 $4,223 - $4,697	-18 Reduced 48.65%	19 $5,000
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $7,318 - $8,981	37 New	37 $9,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Horan Securities, Inc. with notifications on news.

Account

Horan Securities, Inc. Amgen Inc Transaction History